Search Results for "Xopenex"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Xopenex. Results 1 to 7 of 7 total matches.
See also: levalbuterol
Comparison Chart: Correct Use of Inhalers for Asthma (online only)
The Medical Letter on Drugs and Therapeutics • Nov 25, 2024 (Issue 1716)
HFA, ProAir HFA, Proventil HFA, QVAR, Symbicort,
Ventolin HFA,
Xopenex HFA
▶ Shaking required ...
View the Comparison Chart: Correct Use of Inhalers for Asthma
Med Lett Drugs Ther. 2024 Nov 25;66(1716):e196-8 doi:10.58347/tml.2024.1716c | Show Introduction Hide Introduction
Table: Correct Use of Inhalers for COPD (online only)
The Medical Letter on Drugs and Therapeutics • Sep 07, 2020 (Issue 1606)
, Flovent HFA, ProAir
HFA, Proventil HFA, QVAR, Symbicort, Ventolin HFA,
Xopenex HFA, Breztri Aerosphere ...
View the Table: Correct Use of Inhalers for COPD
Airsupra: An Inhaled Albuterol/Budesonide Combination for Asthma
The Medical Letter on Drugs and Therapeutics • Mar 18, 2024 (Issue 1698)
(Teva) DPI (200 inh/unit) 90 mcg/inh 45.00
Levalbuterol – Xopenex HFA (Lupin) HFA MDI (200 inh/unit) 90 ...
The FDA has approved Airsupra (AstraZeneca), a
metered-dose inhaler containing the short-acting
beta2-agonist (SABA) albuterol and the inhaled
corticosteroid (ICS) budesonide, for use as needed for
treatment or prevention of bronchoconstriction and to
reduce the risk of exacerbations in patients ≥18 years
old with asthma. Airsupra is the first combination of
a SABA and an ICS to become available in the US. It is
not approved for use as maintenance therapy.
Med Lett Drugs Ther. 2024 Mar 18;66(1698):41-3 doi:10.58347/tml.2024.1698a | Show Introduction Hide Introduction
Comparison Chart: Some Inhaled Drugs for Treatment of Asthma (online only)
The Medical Letter on Drugs and Therapeutics • Nov 25, 2024 (Issue 1716)
: 1.25-5 mg q4-8h
PRN
20.007
Levalbuterol – Xopenex HFA (Sunovion)
generic
45 mcg/inh HFA MDI (200 ...
View the Comparison Chart: Some Inhaled Drugs for Treatment of Asthma
Med Lett Drugs Ther. 2024 Nov 25;66(1716):e192-5 doi:10.58347/tml.2024.1716b | Show Introduction Hide Introduction
Comparison Table: Inhaled Drugs for Treatment of COPD (online only)
The Medical Letter on Drugs and Therapeutics • Sep 02, 2024 (Issue 1710)
Levalbuterol –
Xopenex HFA (Lupin)
generic
generic
45 mcg/inh
0.31, 0.63, 1.25 mg/3 mL soln
HFA MDI (200 ...
View the Comparison Table: Inhaled Drugs for Treatment of COPD
Med Lett Drugs Ther. 2024 Sep 2;66(1710):e143-7 doi:10.58347/tml.2024.1710b | Show Introduction Hide Introduction
Drugs for COPD
The Medical Letter on Drugs and Therapeutics • Sep 02, 2024 (Issue 1710)
26.405
3 mL soln
Levalbuterol – Xopenex HFA (Lupin) 45 mcg/inh HFA MDI (200 inh/unit) 90 mcg q4-6h PRN ...
The main goals of treatment of chronic obstructive
pulmonary disease (COPD) are to relieve symptoms,
reduce the frequency and severity of exacerbations,
prevent disease progression, and reduce mortality.
GOLD (Global Initiative for Chronic Obstructive Lung
Disease) guidelines for treatment of COPD were
updated recently. Treatment of acute exacerbations
is not discussed here. Drugs available for treatment
of COPD are listed in Tables 1 and 3.
Med Lett Drugs Ther. 2024 Sep 2;66(1710):137-44 doi:10.58347/tml.2024.1710a | Show Introduction Hide Introduction
Drugs for Asthma
The Medical Letter on Drugs and Therapeutics • Nov 25, 2024 (Issue 1716)
Levalbuterol –
Xopenex HFA (Lupin)
generic
generic – single-dose vials
HFA MDI (200 inh/unit)
45 mcg/inh ...
The goal of asthma treatment is to control symptoms,
prevent exacerbations, and maintain normal lung
function. Management of acute exacerbations in the
emergency department is not discussed here.
Med Lett Drugs Ther. 2024 Nov 25;66(1716):185-92 doi:10.58347/tml.2024.1716a | Show Introduction Hide Introduction